Home About Lux The Lux Team Client Portfolio News Contact Information

Lux Capital Management is a research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. Our investment team has built over 20 companies from scratch.

Portfolio - Lux Research
Portfolio - Lux Research
Portfolio - Nanosys
Portfolio - Magen
Portfolio - Cambrios
Portfolio - EverSpin
Portfolio - Cerulean Pharmaceuticals
Portfolio - Genocea
Portfolio - Accelergy
Portfolio - Molecular Imprints
Portfolio - Silicon Clocks
Portfolio - Luxtera
Silicon Clocks Completes $10.3M Series C, Led By Silicon Labs
Luxtera Announces World's First Commercial Silicon CMOS Photonics Process
Genocea Biosciences Closes $23M Series A, Adds New CEO
Everspin Named One of 2008's Most Successful Startups
Sirtris Pharmaceuticals- Co-Founded by Lux Venture Partner David Sinclair - Acquired by GlaxoSmithKline for $720M